18-2590159-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006101.3(NDC80):āc.1012G>Cā(p.Val338Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000376 in 1,597,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006101.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDC80 | NM_006101.3 | c.1012G>C | p.Val338Leu | missense_variant | 10/17 | ENST00000261597.9 | NP_006092.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDC80 | ENST00000261597.9 | c.1012G>C | p.Val338Leu | missense_variant | 10/17 | 1 | NM_006101.3 | ENSP00000261597 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000427 AC: 1AN: 234216Hom.: 0 AF XY: 0.00000789 AC XY: 1AN XY: 126822
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1445308Hom.: 0 Cov.: 31 AF XY: 0.00000417 AC XY: 3AN XY: 718600
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2023 | The c.1012G>C (p.V338L) alteration is located in exon 10 (coding exon 9) of the NDC80 gene. This alteration results from a G to C substitution at nucleotide position 1012, causing the valine (V) at amino acid position 338 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at